Palliative Use of Ionizing Radiations

References

• Parker R. G. Palliative radiation therapy. JAMA 1964; 190: 1000–2
   PubMed Web of Science ®Google Scholar
• Weissman D. E. Cancer pain education: A call for models. J Clin Oncol 1988; 6: 1793–4
   PubMedGoogle Scholar
• Foley K. M., Arbit E. The management of cancer pain. Cancer: Principles and practice of oncology, 4th edition, V. T. DeVita, S. Hellman, S. A. Rosenberg. JB Lippincott., Philadelphia 1993; 2417–8
   Google Scholar
• Porzsolt F., Tannock I. Goals of palliative care therapy. J Clin Oncol 1993; 11: 378–81
   PubMedGoogle Scholar
• Nielsen O. S., Munro A. J., Tannock I. F. Bone metastases: Pathophysiology and management policy. J Clin Oncol 1991; 9: 509–24
   PubMed Web of Science ®Google Scholar
• Mauch P. M., Drew M. A. Treatment of meastatic cancer to bone. Cancer: Principles and practice of oncology, V. T. DeVita, S. Hellman, S. A. Rosenberg. Lippincott, Philadelphia, PA 1985; 2132–41
   Google Scholar
• Lote K., Walloe A., Bjersand A. Bone metastasis. Prognosis diagnosis and treatment. Acta Radiol Oncol 1986; 25: 227–32
   PubMedGoogle Scholar
• Stoll B. A. Natural history, prognosis, and staging of bone metastases. Monitoring and treatment. Raven Press, New York; NY 1983; 1–20
   Google Scholar
• Poulsen H. S., Nielsen O. S., Klee M., et al. Palliative irradiation of bone metastases. Cancer Treat Rev 1989; 16: 41–48
   PubMedGoogle Scholar
• Tong D., Gillick L., Hendrickson F. R. The palliation of symptomatic osseous metastases. Final results of the study by the radiation therapy oncology group. Cancer 1982; 50: 893–9
   PubMed Web of Science ®Google Scholar
• Blitzer P. H. Reanalysis of the RTOG study of the palliation of symptomatic osseous metastases. Cancer 1985; 55: 1468–72
   PubMed Web of Science ®Google Scholar
• Price P., Hoskin P. J., Easton D., et al. Prospective randomized trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases. Radiother Oncol 1986; 6: 247–55
   PubMed Web of Science ®Google Scholar
• Hoskin P. J. Scientific and clinical aspects of radiotherapy in the relief of bone pain. Cancer Surv 1988; 7: 69–86
   PubMedGoogle Scholar
• Hoskin P. J., Ford H. T., Harmer C. L. Hemibody irradiation (HBI) for metastatic bone pain in two distinct groups of patients. Clin Oncol 1989; 1: 67–86
   Google Scholar
• Zucali R. Radiotherapy of bone lesions. Bone resorption, metastasis, and diphosphonates, S. Garattini. Raven Press, New York, NY 1985; 117–26
   Google Scholar
• Zelefsky M. J., Scher H. I., Forman J. D., et al. Palliative hemiskeletal irradiation for widespread metastatic prostate cancer: A comparison of single dose and fractionated regimes. Jnt J Radiat Oncol Biol Phys 1989; 17: 1281–5
   PubMed Web of Science ®Google Scholar
• Nag S., Shah V. Once a week lower hemibody irradiation (HBJ) for metastatic cancers. Int J Radiat Oncol Biol Phys 1986; 12: 1003–5
   PubMedGoogle Scholar
• Robinson R. G., Preston D. F., Schiefelbein M., Baxter K. G. Strontium 89 therapy for the palliation of pain due to osseous metastases. JAMA 1995; 274: 420–4
   PubMed Web of Science ®Google Scholar
• Atkins H. L., Mausher L. F., Srivastava S. C., et al. Biodistribution of Sn-117m (4 +) DTPA for palliative therapy of painful osseous metastases. Radiology 1993; 186: 279–83
   PubMed Web of Science ®Google Scholar
• Porter A. T., McEwan A. J. B., Powe J. E., et al. Results of a randomized phase III trial to evaluate the efficacy of Sr-89 adjuvant to local field external bean irradiation in the management of endocrine resistant metastatic prostate cancer. Int J Radiat Oncol Biol Phys 1992; 25: 805–13
   Google Scholar
• Quilty P. M., Kirk D., Bolger J. J., et al. A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer. Radiother Oncol 1994; 31: 33–40
   PubMed Web of Science ®Google Scholar
• McEwan A. J. B., Amyotti G. A., McGowan D. G., et al. A retrospective analysis of the cost effectiveness of treatment with Metastron (89Sr-chloride) in patients with prostate cancer metastatic to bone. Nucl Med Commun 1984; 15: 449–50
   Google Scholar
• Gilbert R. W., Kim J. H., Posner J. B. Epidural spinal cord compression from metastatic tumor: Diagnosis and treatment. Ann Neurol 1978; 3: 40–51
   PubMed Web of Science ®Google Scholar
• Stark R. J., Henson R. A., Evans S. J. W. Spinal metastasis: A retrospective survey from a general hospital. Brian 1982; 105: 189–213
   PubMed Web of Science ®Google Scholar
• Lien H. H., Blomlie V., Heimdal K. Magnetic resonance imaging of malignant extradural tumors with acute spinal cord compression. Acta Radiol 1990; 31: 187–90
   PubMed Web of Science ®Google Scholar
• Greenberg H. S., Kim J. H., Posner J. B. Epidural spinal cord compression from metastatic tumors: Results with a new treatment protocol. Ann Neurol 1980; 8: 361–6
   PubMed Web of Science ®Google Scholar
• McLntire F. T., Sykes EM. Obstruction of the superior vena cava: A review of the literature and report of two personal cases. Ann Intern Med 1949; 30: 925–60
   PubMedGoogle Scholar
• Fincher R. E. Superior vena cava syndrome: Experience in a teaching hospital. South Med J 1987; 80: 1243–45
   PubMedGoogle Scholar
• Chen J. C., Bongard F., Klein S. R. A contemporary perspective on superior vena cava syndrome. Am J Surg 1990; 160: 207–11
   PubMed Web of Science ®Google Scholar
• Escalante C. P. Causes and management of superior vena cava syndrome. Oncology 1993; 7: 61–8
   PubMedGoogle Scholar
• Armstrong B. A., Perez C. A., Simpson J., et al. Role of irradiation in the management of superior vena cava syndrome. Int J Radiat Oncol Biol Phys 1987; 13: 531–9
   PubMed Web of Science ®Google Scholar
• Ahmann F. R. A reassessment of the clinical implications of the superior vena cava syndrome. J Clin Oncol 1984; 2: 961–9
   PubMedGoogle Scholar
• Lockridge S. K., Knibbe W. P., Doty D. B. Obstruction of the superior vena cava. Surgery 1979; 85: 14
   PubMedGoogle Scholar
• Marder V. J., Bele W. R. Fibrinolytic Therapy 1987. JB Lippincott, Philadelphia, PA 1987; 1393–1437
   Google Scholar
• Bern M. M., Lockich J. J., Wallach S. R., et al. Very low dose warfarin can prevent thrombosis in central venous catheters. Ann Intern Med 1990; 112: 423–8
   PubMed Web of Science ®Google Scholar
• Maddox A. M., Valdivieso M., Lukeman J., et al. Superior vena cava obstruction in small cell bronchogenic carcinoma: Clinical parameters and survival. Cancer 1983; 52: 2165–72
   PubMedGoogle Scholar
• Oudkerk M., Heystraten F. M. J., Stoter G. Stenting in malignant vena cava obstruction. Cancer 1993; 71: 142–6
   PubMedGoogle Scholar
• Borgelt B., Gelber R., Kramer S., et al. The palliation of brain metastases: Final result of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1980; 6: 1–19
   PubMed Web of Science ®Google Scholar
• West J., Maor M. Intracranial metastases: Behavioral patterns related to primary site and results of treatment by whole brain irradiation. Int J Radiat Oncol Biol Phys 1980; 6: 11–15
   PubMed Web of Science ®Google Scholar
• Posner J. Surgery for metastases to the brain. N Engl J Med 1990; 322: 544–5
   PubMed Web of Science ®Google Scholar
• Moses R., Johnson M. Surgical management of brain metastases: How aggressive should we be. Oncology 1989; 3: 123–7
   PubMedGoogle Scholar
• Davis J. M., Zimmerman R. A., Bilarink Lt. Metastases to the central nervous system. Radiol Clin N Am 1982; 20: 417–35
   PubMedGoogle Scholar
• Delattre J., Krol G., Thaler H., Posner J. Distribution of brain metastases. Arch Neurol 1988; 45: 741–4
   PubMed Web of Science ®Google Scholar
• Hoskin P., Crow J., Ford H. The influence of extent and local management on the outcome of radiotherapy for brain metastases. Int J Radiat Oncol Biol Phys 1990; 19: 111–5
   PubMed Web of Science ®Google Scholar
• Coia L. R. The role of radiation therapy in the treatment of brain metastases. Int J Radiat Oncol Biol Phys 1992; 23: 229–38
   PubMedGoogle Scholar
• Borgelt B., Gelber R., Larson M., et al. Ultra-rapid high dose irradiation schedules for the palliation of brain metastases: Final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1981; 7: 1633–8
   PubMed Web of Science ®Google Scholar
• Epstein B. E., Scott C. B., Sause W. T., et al. Improved survival duration in patients with unresected solitary brain metastases using accelerated hyperfractionated radiation therapy at total doses of 54.4 Gy and greater. Cancer 1993; 71: 1362–7
   PubMed Web of Science ®Google Scholar
• Ziegler J., Cooper J. Brain metastases from melanoma: Conventional versus high dose-per-fraction radiotherapy. Int J Radiat Oncol Biol Phys 1986; 12: 1839–42
   PubMed Web of Science ®Google Scholar
• Sauce W. T., Crowley J. J., Townsend J. J., et al. Solitary brain metastasis: Results of an RTOG/SWOG protcol evaluation of surgery and radiation therapy versus radiation alone. Am J Clin Oncol 1990; 13: 427–32
   PubMedGoogle Scholar
• DeAngelis L. M., Mandell L. R., Thaler H. T., et al. The role of postoperative radiotherapy after resection of single brain metastases. Neurosurgery 1989; 24: 798–804
   PubMed Web of Science ®Google Scholar
• Smalley S. R., Schray M. F., Laws E. R., O'Fallon J. R. Adjuvant radiation therapy after surgical resection of solitary brain metastasis: Association with pattern of failure and survival. Int J Radiat Oncol Biol Phys 1987; 13: 1611–6
   PubMed Web of Science ®Google Scholar
• Patchell R. A., Tibbs P. A., Walsh J. W., et al. A randomized trial of surgery in the treatment of single metastases to the brain. Eng J Med 1990; 322: 494–500
   PubMed Web of Science ®Google Scholar
• Flickinger J. C., Kondziolka D., Lunsford L. D., et al. A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys 1994; 28: 797–802
   PubMed Web of Science ®Google Scholar
• Schweitzer V. G., Selch M. T., DeSalles A., et al. Stereotactic irradiation for the treatment of brain metastases. Prognostic factors and the role of whole brain irradiation, (in press).
   Google Scholar
• Adler J. R., Cox R. S., Kaplan I., Martin D. P. Stereotactic radio-surgical treatment of brain metastases. J Neurosurg 1992; 76: 444–9
   PubMed Web of Science ®Google Scholar
• Noyes W. R., Auchter R. M., Craig B., et al. Cost analysis of radiosurgery versus resection for single brain metastases. Radiosurgery 1996; 1: 172–9
   Google Scholar
• DeAngelis L., Currie V., Kim, et al. The combined use of radiation therapy and Lonidamide in the treatment of brain metastases. J Neuro Oncol 1989; 7: 241–7
   PubMed Web of Science ®Google Scholar
• Komamicky L., Philips T., Martz K., et al. A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916). Int J Radiat Oncol Biol Phys 1991; 20: 53–8
   PubMedGoogle Scholar
• Cooper J., Steinfeld A., Lerch I. Cerebral metastases: Value of reirradiation in selected patients. Radiology 1990; 174: 883–5
   PubMed Web of Science ®Google Scholar
• Moss W. T. The orbit in Moss' radiation oncology: Rationale, technique. Results 7th ed. 1994; p. 258
   Google Scholar
• Glassburn J. R., Klionsky M., Brady L. W. Radiation therapy for metastastic disease involving the orbit. Am J Clin Oncol 1984; 1: 145–8
   Google Scholar
• Reddy S., Saxena V. S., Hendrickson F., Deutsch W. Malignant metastastic disease of the eye: Management of an uncommon complication. Cancer 1981; 47: 810–2
   PubMedGoogle Scholar
• Bedwinek J. M., Lee J., Fineberg B., Ocwieza A. B. Prognostic indicators in patients with isolated local-regional recurrence of breast cancer. Cancer 1981; 47: 2232–5
   PubMed Web of Science ®Google Scholar
• Brady L. W., Fletcher G. H., Levitt S. H. Cancer of the breast: The role of radiation therapy after mastectomy. Cancer 1977; 39: 2868–74
   PubMed Web of Science ®Google Scholar
• Toonkel L. M., Fix I., Jacobson L. H., Wallach B. S. The significance of local recurrence of carcinoma of the breast. Int J Radiat Oncol Biol Phys 1983; 9: 33–9
   PubMedGoogle Scholar
• Halverson K. S., Perez C. A., Kuske R. R., et al. Isolated local-regional recurrence of breast cancer following mastectomy: Radiotherapeutic management. Int J Radiat Oncol Biol Phys 1990; 19: 851–8
   PubMed Web of Science ®Google Scholar
• Chen K. K., Montague E., Oswald M. J. Results of irradiation in the treatment of locoregional breast cancer recurrence. Cancer 1985; 56: 1269–73
   PubMed Web of Science ®Google Scholar
• Laramore G. E., Griffin T. W., Parker R. G., et al. The use of electron beams in treating local recurrence of breast cancer in previously irradiated fields. Cancer 1978; 41: 991–5
   PubMed Web of Science ®Google Scholar
• Borner M., Bacchi M., Goldhirsch A., et al. First isolated locoregional recurrence following mastectomy for breast cancer: Results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation. J Clin Oncol 1994; 12: 2071–7
   PubMedGoogle Scholar